Maternal deficiencies in micronutrients affecting one-carbon metabolism before and during pregnancy can influence metabolic status, and degree of insulin resistance and obesity, of the progeny in adulthood. Notably, both maternal and progeny plasma S-adenosylhomocysteine (SAH) levels are elevated following vitamin deficiency in pregnancy. Therefore, we investigated whether this key one-carbon cycle intermediate directly affects adipocyte differentiation and function. We found that expansion and differentiation of murine 3T3-L1 preadipocytes in the presence of SAH, impaired both basal and induced glucose uptake, and lipolysis compared with untreated controls. SAH did not alter preadipocyte factor (Dlk)1 and peroxisome proliferator activated receptor (Ppar)γ 2 but significantly reduced expression of CAAT enhancer binding protein (Cebp)α, Cebpβ and retinoid x receptor (Rxr)α compared to untreated adipocytes. SAH increased Rxrα methylation on a CpG unit (chr2:27,521,057+,chr2:27,521,049+) and CpG residue (chr2:27,521,080+), but not Cebpβ methylation, relative to untreated adipocytes. Trimethylated histone H3-Lys27 occupancy was significantly increased on Cebpα and Rxrα promoters in SAHtreated adipocytes; consistent with the reduction in gene expression. In conclusion, SAH did not affect adipogenesis per se but altered adipocyte functionality through epigenetic mechanisms, such that they exhibited altered glucose disposal and lipolysis. Our findings implicate micronutrient imbalance in subsequent modulation of adipocyte function.
INTRODUCTION
The 'predictive adaptive response' in the context of developmental plasticity proposes that the prenatal environment, in particular the levels of maternal nutrition at peri-conception and during pregnancy, influence the metabolic status and degree of metabolic syndrome of the progeny into adulthood (1, 2) . This germinal concept has since been reiterated in numerous epidemiological studies that not only lend support the envisaged role of environment in setting the progeny's 'epigenetic phenotype', but collectively underpin a contemporary embodiment of the original notion, known as the Developmental Origins of human Health and Disease (DoHAD) (1, 2) .
Within this growing body of epidemiological data seminal investigations have linked maternal deficiencies in key micronutrients such as folate (vitamin B9) and cobalamin (the cobalt containing compounds or vitamin B12s) to fetal pathologies, including preterm birth (3), intrauterine growth retardation and birth size (4-6) and neural tube defects (7) , and as determinants of postnatal insulin resistance and obesity (8, 9) . Of significance, these micronutrients comprise the one-carbon cycle hence highlighting the impact of one carbon metabolism on fetal growth parameters and the potential contribution to the development of offspring insulin resistance and obesity.
Folate and cobalamins are primarily required by the body as dietary precursors for the generation of methyl donor groups in the one-carbon cycle [reviewed in (10) ]. The predominant methyl donor is S-adenosylmethionine (SAM), a metabolic intermediate derived from methionine, and cobalamin is a necessary cofactor in the enzymatic generation of methionine from homocysteine (Hcy). In the course of this process, methionine synthase transfers a methyl group from methyltetrahydrofolate (the native form of folic acid) to Hcy. Thus, the level of Hcy in the circulation is determined by the biological activity of cobalamins and folic acid. After donating its methyl group, SAM is converted to S-adenosylhomocysteine (SAH) which can then be hydrolysed to Hcy once again to complete the cycle (10) . The methyl donor groups are utilized by a range of trans-methylation dependent biochemical reactions and in the synthesis of nucleic acids during rapid cellular growth and elevated DNA synthesis. The generation of methyl donors is also critical for DNA and histone methylation, a major epigenetic process implicated in the regulation of gene expression levels. The latter includes modification of specific genomic sites in the gene body or regulatory regions, and of histone proteins responsible for packing DNA into higher order chromatin structure. In both cases, methylation changes are thought to impact on the accessibility of regulatory factors required to drive or suppress the complex transcriptional hierarchies needed to define functional phenotypes.
It is generally viewed that the adoption of food fortification and folate supplementation programmes has resulted in significant Public Health benefit, reducing the incidence of neural tube defects by as much as 48% in some countries (11). More recent data, from the US National Health And Nutrition Examination Surveys in particular, suggests however that these benefits have not been realized universally across socioeconomic and ethnic groups in the US (12) and specific targeting of high risk and disadvantaged groups would generate further impact. Beyond the US, B9 and B12 deficiencies in pregnancy remain a significant Public Health issue in both low income countries (13) and even some developed nations such as Japan (14) . Notably in Brazilian pregnancy cohorts, women with B12 deficiencies exhibit significantly decreased serum levels of the methyl donor SAM and methionine, but SAH concentrations are significantly elevated (15) . Furthermore, this maternal vitamin deficiency appears to be perpetuated inter-generationally, leading to a similar deficiency in the neonate. These findings suggest that perturbation of the one-carbon cycle resulting from maternal vitamin deficiency may lead to changes in cellular methylation in both the mother and offspring. Further, they suggest a physiological linkage between vitamin deficiency and subsequent patterns of adipogenesis, a process which is known to be significantly influenced by epigenetic mechanisms (16, 17) , and/or adipocyte function.
Adipogenesis is driven by a gene transcriptional program which underpins the conversion of undifferentiated fibroblastic pre-adipocytes into spherical lipid-rich mature functioning adipocytes. Mature adipocytes acquire insulin sensitivity, express the insulin responsive glucose transporter (GLUT)-4 to mediate glucose uptake (18, 19) and express enzymes involved in triacylglycerol metabolism to confer lipogenic and lipolytic functions (18) . Genes that encode enzymes involved in adipocyte glucose and lipid metabolism are regulated in a highly coordinated manner by at least two families of transcription factors, CAAT enhancer binding proteins (CEBPs) and the peroxisome proliferator-activated receptors (PPARs) (18) . In particular, CEBPα has been implicated in maintenance of the adipocyte phenotype as well as promoting insulin sensitive glucose transport (19) .
To establish a molecular link between maternal deficiencies in folate and cobalamin to the differentiation and function of adipocytes, we have used 3T3-L1 cell line, a well characterized in vitro model system of adipogenesis to investigate the consequences of exposure to supraphysiological levels of SAH, mimicking the elevated serum levels observed as a consequence of vitamin deficiencies. Interestingly, while we do not change the rate of adipocyte differentiation, exposure to SAH does lead to altered functionality, with the resulting mature adipocytes exhibiting altered glucose disposal and lipolysis. Further, we define some of the key gene regulators of this altered phenotype and establish a role for epigenetic mechanisms in its manifestation.
EXPERIMENTAL
Materials and antibodies -All chemicals were purchased from Sigma unless otherwise stated.
Cell culture reagents were purchased from Gibco-BRL, Invitrogen. 2-deoxy-d-[1-3H]-glucose (37MBq, 8 Ci/mmol) was purchased from Perkin Elmer, USA.
3T3-L1 cell culture and SAH treatment -Murine 3T3-L1 preadipocytes (American Type Culture
Collection; http://www.atcc.org) were cultured and induced to differentiate using hormonal cocktails as previously described (20) . For all experiments, preadipocytes were seeded at 2500 cells/cm 2 . 24h post seeding, SAH treatment at the indicated doses was initiated and maintained throughout differentiation. Adipocytes 7-8 days post induction of differentiation were used for assays. For RT-qPCR and chromatin immunoprecipitation (ChIP) analyses, cells were harvested 5 days post differentiation.
2-deoxy-d-[1-3H
] glucose transport assay -Assay was performed as previously described (20) .
Cells were stimulated with 100nM insulin for 20min at 37 o C before initiation of glucose transport assay.
Nile red assay -Assay was performed as described previously with minor modifications (21) .
Differentiated adipocytes in 96-well plates were fixed in 4% paraformaldehyde pH 7.4 for 10min
and washed once with PBS followed by incubation with 10µg/ml nile red and 1µg/ml DAPI for 15min. Relative fluorescence intensity for nile red was used as an indicator of lipid accumulation (surrogate for differentiation) and was measured by Biotek Synergy 2 plate reader using 485/528
and 360/460 filter sets. Cell numbers were normalized using DAPI fluorescence.
Lipolysis assay -Differentiated adipocytes were rinsed with PBS twice, incubated in DMEM/2%
BSA for 1h at 37 0 C in the presence of 10µM isoproterenol or vehicle. Media were collected and free glycerol release measured using Free Glycerol Reagent according to manufacturer's instructions (Sigma). Results were normalized to total intracellular protein content.
Immunoblotting -For whole cell lysates, adipocytes were harvested in lysis buffer containing 150mM NaCl, 0.5% Nonidet P-40 and 20mM Tris pH 7.4. Cellular protein concentrations were determined using bichinconinic assay according to manufacturer's instructions (Pierce). 5-10µg
proteins were resolved on SDS-PAGE gel and transferred onto nitrocellulose membrane (BioRad). Antibodies in 1% skim milk were used at the following dilutions: α-H3K4me3, 1:1500; α-H3K27me3, 1:4000; α-H3K9me3, 1:1000; α-H3K9Ac, 1:5000 and α-pan H3-CT, 1:20000 (Millipore). Results were visualised with horseradish peroxidase-conjugated goat antirabbit secondary antibody and enhanced chemiluminescence (Pierce). Immunoblot band intensities were quantified using ImageJ v1.45 software (National Institutes of Health). (22, 23) . Hence, we prepared the cell extracts and measured the metabolites using the combined methods of previous reports with modifications (22) (23) (24) . RT-qPCR and chromatin immunoprecipitation (ChIP) -Total RNA was extracted using Trizol method (Invitrogen). The RNA was incubated with DNAseI (Invitrogen) and 1µg RNA was reverse transcribed using SuperscriptIII according to manufacturer's protocol (Invitrogen). The cDNA was subjected to SYBR Green qPCR (Roche) using gene-specific primers. RNA expression was normalised to Cyclophilin A (Ppia). Results were calculated as Target/Ppia ratio using the Lightcycler480 software (Roche). ChIP was performed as previously described (25) .
SAM, SAH and Hcy detection by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) -Previous reports indicated the importance of stabilising SAM by acidification
Sequences for RT-qPCR and ChIP primers are listed in Table 1 . Table 2 .
DNA methylation assay -
Mass spectral analysis was performed using EpiTyper software v1.0 (Sequenom Inc.). For fragments containing a single CpG site, DNA methylation was calculated by the ratio of methylated to unmethylated fragments. For cleavage products containing multiple CpGs,
EpiTyper reports the methylation values as weighted averages across the fragments.
Statistical analysis -Data was analyzed using IBM SPSS Statistics version 20. Unless indicated in the figure legends, results were analysed using one-way ANOVA with Bonferonni post-hoc test at alpha=0.05. A value of P<0.05 was considered statistically significant.
RESULTS
To assess the effects of SAH on adipogenic differentiation capacity, preadipocytes were cultured and differentiated into mature adipocytes in the absence or presence of SAH. Total intracellular protein and cell numbers were assessed at indicated days of differentiation ( Figure 1A ). 3T3-L1 preadipocytes are known to undergo 2-3 rounds of cell division i.e., mitotic clonal expansion during mid-phase of differentiation (18) . We found that total cell number increased by 3 fold 3-days post differentiation (D3) compared to cells at the onset of differentiation (D0) in both control (untreated) and SAH-exposed cells ( Figure 1A ). Furthermore, both control and SAHexposed cells exhibited similar increase in total intracellular protein (1.5-2 fold at D3, and 5-6
fold at D7 ( Figure 1B ). Preadipocyte factor-1 (Dlk1) is down-regulated during the normal process of adipogenesis (26) . We found that Dlk1 expression declined significantly (p=0.00)
after differentiation in SAH-exposed adipocytes, similar to untreated control ( Figure 1C ). These data indicate that persistent SAH exposure in differentiating preadipocytes did not alter adipogenesis per se.
Following preadipocyte culture and differentiation in the presence of SAH, glucose uptake, lipid accumulation and lipolysis were measured. While basal glucose uptake is mainly mediated by GLUT1, preadipocytes acquire insulin sensitivity upon adipogenesis and exhibit insulinstimulated glucose uptake via GLUT4 (27) . As expected, in the absence of SAH treatment, mature adipocytes exhibited a robust increase in glucose uptake upon stimulation with 100nM insulin ( Figure 1D ). However, adipocytes exposed to 10µM and 100µM SAH reduced basal glucose uptake by 45% (p<0.01) and 30% (p=0.03) respectively ( Figure 1D ). Insulin-stimulated glucose uptake was reduced by 40% at both 10µM (p=0.02) and 100µM (p=0.004) SAH. In addition, the reduced glucose uptake appears to be independent of reduced GLUT1/4 expression and translocation to the plasma membrane (PM) as GLUT1/4 levels in whole cell extracts, as well as PM fractions under basal and insulin-stimulated states, from adipocytes with and without SAH exposure were similar (data not shown).
SAH exposure (10µM and 100µM) did not alter intracellular lipid store ( Figure 1E ). As expected, adipocytes in the absence of SAH showed a robust increase in isoproterenol-stimulated lipolysis ( Figure 1F ). Basal lipolysis was significantly reduced by 70% (p=0.03) in adipocytes treated with 10µM SAH, and 20% (albeit not significant) at 100µM SAH. Isoproterenolstimulated lipolysis was significantly reduced by 50% (p=0.01) and 20% (p=0.03) at 10µM and 100µM SAH respectively, compared to adipocytes without SAH exposure suggesting a dosedependent effect of SAH on lipolysis.
Given that SAH perturbed adipocyte function but not differentiation, we measured RNA levels of several genes involved in adipogenic function. Due to budget limitation, we chose the candidate approach (RT-qPCR) rather than a genome-wide or global method. We found that expression of Pparγ2, a key regulator of adipogenesis (18) was not changed by SAH (Figure 2 ).
This finding is consistent with our earlier results that persistent SAH exposure does not inhibit adipogenesis per se. Furthermore, the expression of retinoic acid x receptor (Rxr)-α, a nuclear receptor which heterodimerises with Pparγ2 to regulate glucose and lipid metabolism in adipocytes (28), was significantly reduced by 50% in (100µM) SAH-treated cells compared to untreated controls (p=0.01; Figure 2 ). Cebpα and Cebpβ expression, both known to play crucial roles in the maintenance of adipogenesis (19, 29) , were reduced by 90% (p=0.00) and 80% (p=0.01) respectively at 100µM SAH compared to adipocytes without exposure. Perhaps unsurprising, we found that Kruppel-like factor (Klf)-4 expression, which induces Cebpβ expression (30), was also significantly inhibited by 80% at both 10µM and 100µM SAH (p=0.00).
Given that adipogenic differentiation is regulated epigenetically (16, 17) , we investigated whether SAH-mediated inhibition of genes expression is associated with changes in DNA methylation.
Following adipogenic differentiation in the absence or presence of SAH, genomic DNA was extracted, bisulfite-converted and Klf4, Cebpα, Cebpβ and Rxrα genomic regions were assessed for changes in CpG methylation. We found that CpG methylation was unchanged for Klf4
( Figure 3A) and Cebpβ ( Figure 3B ) promoter regions despite the SAH-mediated reduced expression of these genes. Due to the nature of the sequence surrounding the CpG site of interest containing repeats, we could not measure Cebpα methylation; this amplicon failed PCR amplification despite our numerous attempts (data not shown). We found that Rxrα methylation on two of five CpG residues within intron 1, proximal to the promoter, were relatively unchanged in both SAH-exposed and non-exposed adipocytes; chr2:27,521,169+ and chr2:27,521,208+ ( Figure 3C ). In contrast, we detected a significant 10% increase in methylation of a CpG unit containing two CpG residues (chr2:27,521,057+, chr2:27,521,049+; p=0.00) and on a single CpG residue at chr2:27,521,080+ (p=0.02) in adipocytes exposed to both 10µM and 100µM SAH compared to adipocytes in the absence of SAH.
We next examined if adipocytes maintained in a persistently elevated SAH milieu alters histone modifications. H3-K27 trimethylation (H3K27me3) was suppressed by 4 fold (p=0.02) in differentiated adipocytes compared to undifferentiated pre-adipocytes without SAH treatment ( Figure 4A and Cebpα genes by 4 fold compared to adipocytes without SAH exposure (p=0.00 and p=0.01 respectively; Figure 4B ). Similarly, H3K27me3 occupancy was significantly increased at the promoter of Rxrα by 2 fold in adipocytes exposed to 100µM SAH compared to adipocytes without SAH exposure (p=0.00).
To determine whether the metabolic alterations in these adipocytes are contributed by SAH, we measured intracellular SAH, SAM and Hcy, and SAH in the media collected at the end of the treatment regime. In media containing exogenous 10µM and 100µM SAH, we detected 0.5 -/+ 0.1µM and 7.0 -/+ 0.9µM SAH respectively (mean -/+ s.d.; Figure 5A ). Media from untreated control was below the LC-MS/MS limit of detection of 0.02µM ( Figure 5A ). Our model reflects a physiologically relevant state given that the effective exogenous SAH concentrations used in this system lies well within an order of magnitude to the previously reported circulating plasma SAH levels in human (15) . We found that the intracellular SAH in adipocytes exposed to exogenous 10µM and 100µM SAH was elevated by at least 2 and 5 fold respectively, over untreated control ( Figure 5B ). Interestingly, we detected only modest increases in both intracellular SAM and Hcy; 1.3 fold and 1.4 fold over untreated control for SAM; 1.3 and 1.6
fold over untreated control for Hcy at 10µM and 100µM exogenous SAH respectively ( Figure   5B ). These results are consistent with our hypothesis that exposure to elevated SAH may induce metabolic changes in adipocytes. In addition, our data suggests that increasing intracellular SAH alone does not necessarily drive a change in the one-carbon cycle flux (i.e., methyl donor availability) given the lack of an appreciable change in intracellular SAM and Hcy.
In summary, persistent SAH exposure in differentiating preadipocytes reduces glucose uptake and lipolysis in differentiated adipocytes. The SAH-mediated reduction in adipocyte functionality likely occurs through reduced expression of nodal regulators of transcriptional pathways such as Klf4, Cebpα/β and Rxrα, which are involved in glucose and lipid metabolism.
The reduced expression of these genes appear to be epigenetically regulated via increased promoter occupancy of H3K27me3 and in the case of Rxrα, perhaps also through changes in DNA methylation.
DISCUSSION
Increasing evidence suggests that the maternal nutritional state can influence adipose tissue biology in the offspring (31) (32) (33) . In this study, we found that adipocytes which were differentiated in vitro in the presence of elevated SAH express an altered adipogenic functionality and gene expression, although pre-adipocyte proliferation, rates of differentiation and adipocyte cell numbers appear to be normal. Notably, the differentiated adipocytes exhibit impaired glucose uptake and lipolysis. Consistent with these impairments, we demonstrate significant SAH-induced changes in the expression of pivotal regulators of adipocyte function.
Reduced Rxrα expression would alter a number of effector genes involved in adipocyte function (28) . Notably, the loss of Rxrα would affect the formation of the heterodimer complex with Pparγ (28). The other critical transcriptional factor affected by SAH is Cebpα, which has been shown to promote insulin sensitive glucose transport (19, 34) . Significantly, changes in histone modifications appear to be of primary importance in mediating these nutritionally driven effects on adipocyte function.
The primary role of fat tissue is to uptake and store excess glucose in the form of lipid droplets, and in times of need recover this energy through the process of lipid breakdown. Both of these key functions appear to be disrupted in adipocytes differentiated in the presence of elevated levels of the one carbon cycle intermediate SAH. Our finding that persistent SAH exposure impairs lipolysis implies that conditions that perturb one carbon metabolism in differentiating preadipocytes may contribute to the lowering of released free fatty acids by suppressing lipolysis in these adipocytes once matured. Consistent with this notion, Li et al. reported that multivitamin supplementation in a group of Chinese obese/overweight cohort improved the subjects' lipid profile (35) . Of significance, SAH's ability to impair adipocyte glucose uptake in particular under resting state implicates the potential adverse impact of changes in one carbon metabolism on adipose glucose disposal. This is of huge physiological relevance given that pre-diabetes is a high-risk state for diabetes, especially in individuals who remain pre-diabetic despite intensive lifestyle intervention, and that reversion to normal glucose regulation significantly reduces the risk of future diabetes (36) . One might speculate that high SAH level predicts an improvement in lipid profile, thence the metabolic status, in the subjects. However, it remains unclear how the impaired glucose uptake may contribute to impairment of the overall glucose disposal in subjects with elevated SAH. How changes in one carbon metabolism (particularly through nutritional variation) modulate adipocyte glucose disposal warrants further investigation.
Nutrient imbalances can lead to changes in the epigenetic state of tissues through genome wide alteration of DNA methylation and chromatin chemistry (16, 17, 31) . For example, it has been appreciated for some time that depletion of folate results in hypomethylation of genomic DNA in both human (37) and animal models (38) . DNA methylation is however a dynamic and reversible process, such that reinstating a folate-enriched diet is sufficient to restore the normal DNA methylation status of tissues (39) . The principal metabolic role of micronutrients such as folate is to generate the one carbon cycle intermediate and universal methyl donor SAM. Not surprisingly, more direct disruption of nutrient-dependent SAM-derived methyl group generation also results in hypomethylation of genomic DNA (40) . However, changes in 'global' genomic methylation do not necessarily translate to altered promoter methylation states at specific loci (41, 42) demonstrating that the mechanisms underlying DNA methylation are tightly directed and regulated, rather than passive. Indeed, we found that the SAH-mediated suppression of gene expression at selective loci of key adipogenic genes was not generally associated with changes in promoter DNA methylation. Notably, only Rxrα gene repression was accompanied by significantly increased methylation at specific CpG sites. Given that we have recently shown that the promoter methylation status of RXRα is predictive of future adiposity in retrospective human cohort studies (43) the current findings are consistent with, and extend the notion that RXRα gene methylation is a significant determinant of fat cell biological function.
The other widely recognized epigenetic mechanism for gene regulation involves the highly choreographed chemical modification of specific histone residues, which results in changes to chromatin structure and thus influence transcription factor access and binding. In particular, the histone modification H3K27me3 has been widely linked to the repression of transcription elongation (44) leading to inhibition of gene expression. In adipocytes undergoing differentiation in the presence of elevated SAH, we found significantly enhanced promoter occupancy by H3K27me3 in several relevant target genes (Rxrα and Klf4) suggesting that repression of these genes was occurring through histone dependent mechanisms rather than by direct promoter DNA methylation; a caveat being that few CpG sites at the promoter of these genes were investigated.
Interestingly, we also observed increased H3K4me3 in mature adipocytes differentiated under the same conditions. Although methylation is generally linked to gene repression, methylation of the H3K4 residue is considered to be a permissive mark that enhances the initiation of transcription (45) . Indeed, quantitative modeling of the genome wide distribution of the H3K4me3 mark suggests that it may even be highly predictive of expression at promoters which have a low CpG content (46) . In many human cells, H3K4me3 occurs as a part of a 'bivalent' chromatin structure in which its role as a primer of transcriptional activity is held in check by the presence of a more dominant repressive mark such as H3K27me3 (45) . Our observations suggest that adipocyte gene repression and the resultant shift in adipocyte biology resulting from elevated SAH exposure may occur through the enhanced formation of a bivalent chromatin complex.
Our findings are consistent with that of previous studies which showed that changes in SAH level alone, rather than SAM, drives changes in SAM:SAH ratios in various tissues (47, 48) suggesting a regulatory role for SAH in determining overall levels of cellular methylation.
Methylation potential could presumably be altered by influencing the availability of methyl donor groups and/or modifying the activities of various types methyltransferases that catalyze the transfer of the methyl group from SAM to a variety of biomolecules including histones (49). Our study suggests that elevating intracellular SAH alone does not necessarily alter global methyl donor availability. However, as SAH is an established and potent inhibitor of DNA and histone methyltransferase activities (49), we conclude that exposure to elevated SAH drives phenotypic change through its capacity to inhibit cellular methylation.
In conclusion, the current study provides evidence that nutritionally driven signaling through one carbon metabolism can influence metabolic adaptive plasticity. Specifically, while not appearing to alter adipocyte differentiation in vitro, it may influence the functionality of the mature adipocyte and does so via epigenetic mechanisms. 
